Diseases & Illness |

PML News

MS Drug Tysabri Not Yet Reinstated Due to PML Fears

RSS News Feeds
Disease from Products
PML
 All RSS Feeds

At a glance:

A controversial drug for multiple sclerosis is not yet back on the market.
 
Tysabri was available in the US for only three months when it was recalled due to concern that it was linked to cases of a rare brain disease, progressive multifocal leukoencephalopathy (PML).
 
An FDA advisory panel recommends reinstatement in view of its success treating MS and the lack of any new cases of PML, but the FDA has delayed the decision until June.

Ruling on MS Drug Tysabri Delayed

Los Angeles Times - 3/23/2006 3:03 AM

In November 2004, the FDA approved Tysabri for sale to the approximately 350,000 people in the United States who suffer from MS, an incurable disease of the central nervous system.
 
But Elan and Biogen withdrew the drug three months later, after three people taking Tysabri in clinical trials contracted a rare, often fatal brain disease called progressive multifocal leukoencephalopathy, or PML. Two of them died. Both companies subsequently said they found no additional PML cases amon
 
· Read The Full PML Article From Los Angeles Times -->

· Read All PML News Stories -->

Comments On PML News Articles:


No Current Comments
Posted by Admin on 3/20/2006

There are no current comments. Why not post one?

Leave a Comment:

Once you click the 'Save Comment' button, you will receive a verification email from our website. Be sure to change any spam settings to allow webmaster@lawsuitsearch.com as a trusted sender.
 
If you are already a member, you can Sign In Here.
 
You can create your own FREE user account that you can use to participate in our message boards, blogs, newsletters and other community activities such as this one. To get your FREE user account, click here.

Email Address:

Your Name:

Message Title:

Message: